Twelve months after releasing a roadmap to shift away from animal testing requirements, the FDA has declared mission ...
Animal testing has shaped medicine for decades. Discover new alternatives, changing laws, and the future of humane science.
If non-animal testing models like organoids are used correctly, experts note they can cut failure rates and facilitate ...
Add Yahoo as a preferred source to see more of our stories on Google. This week, the Trump administration released new draft guidance meant to steer drugmakers toward alternatives to animal testing. - ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...
New grants support organoids, organs-on-chips, and in silico approaches to reduce reliance on animal models, but experts say ...
Merck KGaA plans to phase out most animal testing in favor of new approach methodologies (NAMs) such as organs-on-a-chip and organoids over the next decade. The move aligns with a global regulatory ...
Merck KGaA plans to replace most of its animal testing with advanced non-animal models over the next ten years, reflecting a global push for more human-relevant preclinical methods. At the 2026 ...
When we imagine the process of developing new drugs, we often picture scientists working with cutting-edge technology in gleaming laboratories. But there’s a side of pharmaceutical research that is ...
When developing new therapies for diseases, biotech researchers are often limited by two time-consuming steps: first, screening thousands of drug candidates in test tubes and second, taking the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results